Trillium Therapeutics Inc. (TRIL): Price and Financial Metrics
Today's Latest Price: $12.30 USD
Oct 26 4:00pm Add TRIL to Watchlist Sign Up
TRIL Price/Volume Stats
Trillium Therapeutics Inc. (TRIL) Company Bio
Trillium Therapeutics develops therapies for the treatment of cancer. The company was founded in 2004 and is based in Toronto, Canada.
TRIL Latest News Stream
All News Types
Commentary Corp. News Debt Offering Earnings New Coverage (Bullish) New Coverage (Neutral) Product News PT Lowered PT Set (Bullish) Rating Reiterated (Bullish) Stock Offering
Loading, please wait...
Latest TRIL News From Around the Web
Below are the latest news stories about Trillium Therapeutics Inc that investors may wish to consider to help them evaluate TRIL as an investment opportunity.
Stock markets remain shaky despite the dramatic rebound following the March crash. However, a sequel could be worse. Only the Trillium Therapeutics stock seems to be defying the pandemic. Analysts see explosive growth down the road. The post Market Crash 2020: The Next Drop Will Be Much Worse appeared first on The Motley Fool Canada .
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) 10X Genomics Inc (NASDAQ: TXG ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) Avenue Therapeutics Inc (NASDAQ: ATXI ) Avidity Biosciences Inc (NASDAQ: RNA ) BioLife Solutions Inc (NASDAQ: BLFS ) Denali Therapeutics Inc (NASDAQ: DNLI ) Guardant Health Inc (NASDAQ: GH ) Immunomedics, Inc. (NASDAQ: IMMU ) - announced a deal to be bought by Gilead Sciences, Inc. (NASDAQ: GILD ) for $21 billion Inspire Medical Systems Inc (NYSE: INSP ) Kintara Therapeutics Inc (NASDAQ: KTRA ) Kura Oncology Inc (NASDAQ: KURA ) Nurix Therapeutics Inc (NASDAQ: NRIX ) Pacific Biosciences of California Inc (NASDAQ: PACB ) (announced the appointment of Susan Kim as CFO, effective Sept. 28) Shockwave Medical Inc (NASDAQ: SWAV ) SI-Bone Inc (NASDAQ...
Trillium Therapeutics (TRIL) has priced its public offering of 10M common shares at $13.00/share, for expected gross proceeds of ~$130M. Underwriters' over-allotment is an additional 1.5M shares. Net proceeds will be used for ongoing and planned clinical trials for CD47 program, for working capital and general corporate purposes.Closing date is...
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 10) Agenus Inc (NASDAQ: AGEN ) Akouos Inc (NASDAQ: AKUS ) BioLife Solutions Inc (NASDAQ: BLFS ) Checkpoint Therapeutics Inc (NASDAQ: CKPT ) ESSA Pharma Inc (NASDAQ: EPIX ) Fortress Biotech (NASDAQ: FBIO ) Harmony Biosciences Holdings Inc (NASDAQ: HRMY ) Inspire Medical Systems Inc (NYSE: INSP ) Kintara Therapeutics Inc (NASDAQ: KTRA ) Kura Oncology Inc (NASDAQ: KURA ) Protagonist Therapeutics Inc (NASDAQ: PTGX ) RedHill Biopharma Ltd (NASDAQ: RDHL ) Silk Road Medical Inc (NASDAQ: SILK ) Shockwave Medical Inc (NASDAQ: SWAV ) Trillium Therapeutics Inc (NASDAQ: TRIL ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 10) ADiTx Therapeutics Inc (NASDAQ: ADTX ) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC )(reac...
Trillium (TRIL) commences a public offering of 8.5M common shares. Price and terms have yet to be announced.Shares down 4% after hours....
Read More 'TRIL' Stories Here
TRIL Price Returns
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 0.7461 seconds.